POS0455 TOFACITINIB DECREASES INFLAMMATORY MARKERS AND MITOCHONDRIAL MORPHOLOGICAL DAMAGE IN SALIVARY GLANDS OF A MURINE MODEL OF SJÖGREN'S SYNDROME

Barrera, M. J., Castro, I., Carvajal, P., Aguilera, S., Jara, D., González, S., … González, M. J. (2022). POS0455 TOFACITINIB DECREASES INFLAMMATORY MARKERS AND MITOCHONDRIAL MORPHOLOGICAL DAMAGE IN SALIVARY GLANDS OF A MURINE MODEL OF SJÖGREN’S SYNDROME. Annals of the Rheumatic Diseases, 81, 481–482. https://doi.org/10.1136/annrheumdis-2022-eular.2110